Cymabay Therapeutics Inc (CBAY.OQ)
CBAY.OQ on NASDAQ Stock Exchange Global Select Market
8.73USD
11 Dec 2018
8.73USD
11 Dec 2018
Change (% chg)
$0.00 (+0.00%)
$0.00 (+0.00%)
Prev Close
$8.73
$8.73
Open
$8.91
$8.91
Day's High
$8.92
$8.92
Day's Low
$8.62
$8.62
Volume
82,903
82,903
Avg. Vol
166,314
166,314
52-wk High
$15.59
$15.59
52-wk Low
$7.39
$7.39
About
CymaBay Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies to treat metabolic diseases, including serious rare and orphan diseases. The Company's product candidates include Arhalofenate, MBX-8025 and MBX-2982. Arhalofenate is used to treat gout. MBX-8025 is a... (more)
Overall
| Beta: | 2.08 |
| Market Cap(Mil.): | $358.81 |
| Shares Outstanding(Mil.): | 43.76 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CBAY.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 92.25 | 33.63 |
| EPS (TTM): | -1.06 | -- | -- |
| ROI: | -182.71 | 0.29 | 15.02 |
| ROE: | -308.78 | 0.94 | 16.60 |
Estimates